Back to Search Start Over

IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia.

Authors :
Tsuji-Takayama K
Harashima A
Tahata H
Izumi N
Nishida Y
Namba M
Okuda Y
Ohta T
Kurimoto M
Source :
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 1996 Jun; Vol. 16 (6), pp. 447-51.
Publication Year :
1996

Abstract

The effects of interferon-gamma (IFN-gamma) on platelet recovery were examined in mice with marrow aplasia induced by i.p. injection of 250 mg/kg of 5-fluorouracil (5-FU). The cytokine was administrated by microosmotic pump, with an ability to deliver a consistent intact dose of cytokine for 7 consecutive days. Administration of 250 IU/kg/day of IFN-gamma in combination with 10(3) U/kg/day of IL-3, which alone had no effect on platelet counts, diminished the nadir for platelet count and shortened the duration of thrombocytopenia. The effect was comparable to that of higher doses of IL-3 (10(5) U/kg/day). The administration of 250 IU/kg/day of IFN-gamma in combination with 10(3) U/kg/day of IL-3 also induced megakaryocyte proliferation in bone marrow cell cultures. Single administration of either 250 IU/kg/day of IFN-gamma or 10(3) U/kg/day of IL-3 had no significant effects. The effect of this combination was also comparable to that of a higher dose of IL-3 (10(5) U/kg/day). We suggest that IFN-gamma accelerates megakaryocyte development, which leads to platelet production in chemotherapy-induced marrow aplasia. The administration of IFN-gamma in combination with IL-3 might be useful for the management of marrow aplasia.

Details

Language :
English
ISSN :
1079-9907
Volume :
16
Issue :
6
Database :
MEDLINE
Journal :
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Publication Type :
Academic Journal
Accession number :
8807498
Full Text :
https://doi.org/10.1089/jir.1996.16.447